On ECHEMI
Home > Drugs > Shenyang Red Flag Pharmaceutical Co., Ltd.
Shenyang Red Flag Pharmaceutical Co., Ltd.
  • Founded in:

    1998-10-30
  • Country:

    China China
  • Address:

    No. 6 Xinluo Street, Hunnan New District, Shenyang
  • Tax NO.:

    912101121178724277
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

Related Drugs
Ethambutol Hydrochloride Tablets
The main ingredient of this product is ethambutol hydrochloride tablets, and its chemical name is [2R,2[S-(R*,R*)]-R]-()2,2'-(1,2-ethylenediimino)-bis-1-butanol dihydrochloride
Name Description Content CAS NO. Registered Holders
Ethambutol dihydrochloride

This product is a synthetic antibacterial anti-tuberculosis drug that can penetrate into mycobacteria to interfere with RNA synthesis, thereby inhibiting bacterial reproduction. It is only effective against mycobacteria in the growth and reproduction period. So far, no cross-resistance has been found between this product and other anti-tuberculosis drugs.

More

This product is a synthetic antibacterial anti-tuberculosis drug that can penetrate into mycobacteria to interfere with RNA synthesis, thereby inhibiting bacterial reproduction. It is only effective against mycobacteria in the growth and reproduction period. So far, no cross-resistance has been found between this product and other anti-tuberculosis drugs.

1070-11-7 13
Indomethacin suppositories
Indomethacin
Name Description Content CAS NO. Registered Holders
Indometacin

This product is a non-steroidal anti-inflammatory analgesic that has the effect of inhibiting the synthesis of prostaglandins. Its anti-inflammatory, analgesic and antipyretic effects may be related to the inhibition of prostaglandin synthesis. Due to the high incidence of adverse reactions of this product, it is only used clinically for its anti-inflammatory and analgesic effects, and is not used solely as a general antipyretic and analgesic.

More

This product is a non-steroidal anti-inflammatory analgesic that has the effect of inhibiting the synthesis of prostaglandins. Its anti-inflammatory, analgesic and antipyretic effects may be related to the inhibition of prostaglandin synthesis. Due to the high incidence of adverse reactions of this product, it is only used clinically for its anti-inflammatory and analgesic effects, and is not used solely as a general antipyretic and analgesic.

53-86-1 23
Indomethacin suppositories
Indomethacin
Name Description Content CAS NO. Registered Holders
Indometacin

This product is a non-steroidal anti-inflammatory analgesic that has the effect of inhibiting the synthesis of prostaglandins. Its anti-inflammatory, analgesic and antipyretic effects may be related to the inhibition of prostaglandin synthesis. Due to the high incidence of adverse reactions of this product, it is only used clinically for its anti-inflammatory and analgesic effects, and is not used solely as a general antipyretic and analgesic.

More

This product is a non-steroidal anti-inflammatory analgesic that has the effect of inhibiting the synthesis of prostaglandins. Its anti-inflammatory, analgesic and antipyretic effects may be related to the inhibition of prostaglandin synthesis. Due to the high incidence of adverse reactions of this product, it is only used clinically for its anti-inflammatory and analgesic effects, and is not used solely as a general antipyretic and analgesic.

53-86-1 23
Yifu Tablets
This product is a compound preparation, the active ingredients of which are rifampicin and isoniazid.
Name Description Content CAS NO. Registered Holders
Rifampicin

It has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells; it firmly binds to the beta subunit of the DNA-dependent RNA polymerase, inhibits the synthesis of bacterial RNA, prevents the enzyme from connecting to DNA, thereby blocking the RNA transcription process and stopping the synthesis of DNA and protein.

More

It has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells; it firmly binds to the beta subunit of the DNA-dependent RNA polymerase, inhibits the synthesis of bacterial RNA, prevents the enzyme from connecting to DNA, thereby blocking the RNA transcription process and stopping the synthesis of DNA and protein.

13292-46-1 24
Isoniazid

It has a highly selective bactericidal effect on all types of Mycobacterium tuberculosis, with a strong effect on Mycobacterium tuberculosis in the growing and multiplying stage, and a weaker and slower effect on Mycobacterium tuberculosis in the dormant stage; it may inhibit the synthesis of mycolic acid in sensitive bacteria and cause the cell wall to rupture.

More

It has a highly selective bactericidal effect on all types of Mycobacterium tuberculosis, with a strong effect on Mycobacterium tuberculosis in the growing and multiplying stage, and a weaker and slower effect on Mycobacterium tuberculosis in the dormant stage; it may inhibit the synthesis of mycolic acid in sensitive bacteria and cause the cell wall to rupture.

54-85-3 19
Ethylamine, pyrazine, and rifampicin tablets
Each tablet contains 0.15g of rifampicin (C43H58N4O12), 0.075g of isoniazid (C6H7N3O), 0.4g of pyrazinamide (C5H5N3O), and 0.275g of ethambutol hydrochloride (C10H24N2O2·2HCl).
Name Description Content CAS NO. Registered Holders
Rifampicin

Not yet clear

More

Not yet clear

0.15g 13292-46-1 24
Isoniazid

Not yet clear

More

Not yet clear

0.075g 54-85-3 19
Pyrazinamide

Not yet clear

More

Not yet clear

0.4g 98-96-4 21
Ethambutol dihydrochloride

Not yet clear

More

Not yet clear

0.275g 1070-11-7 13
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.